Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
•
Stereotactic Radiosurgery
What rate of second malignancies do you quote for patients receiving radiosurgery for benign CNS tumors?
Answer from: Radiation Oncologist at Community Practice
<1% at 10 years based on following Lancet Oncology paper: https://www.ncbi.nlm.nih.gov/pubmed/30473468
Comments
Radiation Oncologist at Bismarck Cancer Center
Agree - timely question given recency of the publi...
Radiation Oncologist at Radiant Oncology
Thank you both for the references! At the core of ...
Radiation Oncologist at Bismarck Cancer Center
That's a good question, and I agree with your conc...
Radiation Oncologist at Bismarck Cancer Center
(apologies, cut off) I think your non-threshold l...
Radiation Oncologist at Bismarck Cancer Center
up to 1% at 10y and 1-2% at 20y is a pretty reason...
1275
1276
1277
1278
1279
Sign in or Register to read more
5029
Related Questions
How do you use Boswellia for radiation necrosis?
How do you approach the management of a patient with lumbar spinal metastasis with neurologic symptoms but without evidence of spinal cord compression?
In a young patient with recurrent low-grade glioma s/p gross total resection, is there any role for further observation instead of radiation and chemotherapy?
How do you approach treatment of sub-total resected ZFTA fusion ependymoma after radiation therapy in a young adult?
Do you routinely prescribe memantine for patients who will be receiving hippocampal sparing whole brain RT if they are already on donepezil, or is donepezil alone sufficient?
Would you offer adjuvant radiation therapy in a young adult with NF1 who has a craniopharyngioma s/p STR?
Would you recommend adjuvant neck radiation for metastatic chordoma to cervical lymph node, s/p neck dissection, with 1/10 positive nodes and no residual on post op imaging?
For patients with metastatic cancer on a systemic therapy regimen that includes bevacizumab, are you comfortable treating brain metastases (SRS or WBRT) without holding bevacizumab?
Do you refer all patients with new findings of CNS or epidural mets/tumor to ED for evaluation or are there some that can be managed completely outpatient?
How would you manage a very large diffuse skull base meningioma involving the olfactory groove, bilateral cavernous sinuses, and abutting optic chiasm that is not amenable to surgical resection?
Agree - timely question given recency of the publi...
Thank you both for the references! At the core of ...
That's a good question, and I agree with your conc...
(apologies, cut off) I think your non-threshold l...
up to 1% at 10y and 1-2% at 20y is a pretty reason...